66 related articles for article (PubMed ID: 31922231)
1. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
[TBL] [Abstract][Full Text] [Related]
2. Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway.
Jiang QG; Xiong CF; Lv YX
Mol Cell Biochem; 2021 Feb; 476(2):727-739. PubMed ID: 33201383
[TBL] [Abstract][Full Text] [Related]
3. 80MAP17 promotes the tumorigenesis of papillary thyroid carcinoma by reducing the stability of p53.
Yu K; Lu H; Chen Y; Xin Y; Tan Z; Yang Q
Front Biosci (Landmark Ed); 2021 Oct; 26(10):777-788. PubMed ID: 34719205
[No Abstract] [Full Text] [Related]
4. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract][Full Text] [Related]
5. Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway.
Xu Q; Yu Z; Mei Q; Shi K; Shen J; Gao G; Liu S; Li M
Aging (Albany NY); 2024 Apr; 16(8):7060-7072. PubMed ID: 38656878
[TBL] [Abstract][Full Text] [Related]
6. PPM1D activity promotes the replication stress caused by cyclin E1 overexpression.
Martinikova AS; Stoyanov M; Oravetzova A; Kok YP; Yu S; Dobrovolna J; Janscak P; van Vugt M; Macurek L
Mol Oncol; 2024 Jan; 18(1):6-20. PubMed ID: 37067201
[TBL] [Abstract][Full Text] [Related]
7. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Khadka P; Reitman ZJ; Lu S; Buchan G; Gionet G; Dubois F; Carvalho DM; Shih J; Zhang S; Greenwald NF; Zack T; Shapira O; Pelton K; Hartley R; Bear H; Georgis Y; Jarmale S; Melanson R; Bonanno K; Schoolcraft K; Miller PG; Condurat AL; Gonzalez EM; Qian K; Morin E; Langhnoja J; Lupien LE; Rendo V; Digiacomo J; Wang D; Zhou K; Kumbhani R; Guerra Garcia ME; Sinai CE; Becker S; Schneider R; Vogelzang J; Krug K; Goodale A; Abid T; Kalani Z; Piccioni F; Beroukhim R; Persky NS; Root DE; Carcaboso AM; Ebert BL; Fuller C; Babur O; Kieran MW; Jones C; Keshishian H; Ligon KL; Carr SA; Phoenix TN; Bandopadhayay P
Nat Commun; 2022 Feb; 13(1):604. PubMed ID: 35105861
[TBL] [Abstract][Full Text] [Related]
8. PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.
Miller PG; Sperling AS; Mayerhofer C; McConkey ME; Ellegast JM; Da Silva C; Cohen DN; Wang C; Sharda A; Yan N; Saha S; Schluter C; Schechter I; Słabicki M; Sandoval B; Kahn J; Boettcher S; Gibson CJ; Scadden DT; Stegmaier K; Bhatt S; Lindsley RC; Ebert BL
Blood; 2023 Dec; 142(24):2079-2091. PubMed ID: 37595362
[TBL] [Abstract][Full Text] [Related]
9.
Kahn JD; Miller PG; Silver AJ; Sellar RS; Bhatt S; Gibson C; McConkey M; Adams D; Mar B; Mertins P; Fereshetian S; Krug K; Zhu H; Letai A; Carr SA; Doench J; Jaiswal S; Ebert BL
Blood; 2018 Sep; 132(11):1095-1105. PubMed ID: 29954749
[TBL] [Abstract][Full Text] [Related]
10. Detectible mosaic truncating PPM1D mutations, age and breast cancer risk.
Machiela MJ; Myers TA; Lyons CJ; Koster R; Figg WD; Colli LM; Jessop L; Ahearn TU; Freedman ND; García-Closas M; Chanock SJ
J Hum Genet; 2019 Jun; 64(6):545-550. PubMed ID: 30850729
[TBL] [Abstract][Full Text] [Related]
11. Ppm1d truncating mutations promote the development of genotoxic stress-induced AML.
Burocziova M; Danek P; Oravetzova A; Chalupova Z; Alberich-Jorda M; Macurek L
Leukemia; 2023 Nov; 37(11):2209-2220. PubMed ID: 37709843
[TBL] [Abstract][Full Text] [Related]
12. PDZK1IP1 gene promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Zhang W; Zheng D; Jin L; Hirachan S; Bhandari A; Li Y; Chen B; Lu Y; Wen J; Lin B; Zhang X; Chen C
Pathol Res Pract; 2022 Oct; 238():154091. PubMed ID: 36057192
[TBL] [Abstract][Full Text] [Related]
13.
Zhang L; Hsu JI; Braekeleer ED; Chen CW; Patel TD; Martell AG; Guzman AG; Wohlan K; Waldvogel SM; Urya H; Tovy A; Callen E; Murdaugh R; Richard R; Jansen S; Vissers L; de Vries BBA; Nussenzweig A; Huang S; Coarfa C; Anastas JN; Takahashi K; Vassiliou G; Goodell MA
bioRxiv; 2024 Jan; ():. PubMed ID: 37693622
[TBL] [Abstract][Full Text] [Related]
14. Clonal haematopoiesis is not prevalent in survivors of childhood cancer.
Collord G; Park N; Podestà M; Dagnino M; Cilloni D; Jones D; Varela I; Frassoni F; Vassiliou GS
Br J Haematol; 2018 May; 181(4):537-539. PubMed ID: 28369776
[No Abstract] [Full Text] [Related]
15. PPM1D inhibition may allow us to WIP leukemia.
Marcellino BK
Blood; 2023 Dec; 142(24):2040-2042. PubMed ID: 38095924
[No Abstract] [Full Text] [Related]
16. Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.
Vasko V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835455
[TBL] [Abstract][Full Text] [Related]
17. Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma.
Martinikova AS; Burocziova M; Stoyanov M; Macurek L
Cells; 2020 Sep; 9(9):. PubMed ID: 32927737
[TBL] [Abstract][Full Text] [Related]
18. CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis.
Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
J Endocrinol Invest; 2021 Feb; 44(2):353-362. PubMed ID: 32500444
[TBL] [Abstract][Full Text] [Related]
19. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
20. The role of PPM1D in cancer and advances in studies of its inhibitors.
Deng W; Li J; Dorrah K; Jimenez-Tapia D; Arriaga B; Hao Q; Cao W; Gao Z; Vadgama J; Wu Y
Biomed Pharmacother; 2020 May; 125():109956. PubMed ID: 32006900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
